ATP2B2
Plasma membrane calcium-transporting ATPase 2
Also known as: AT2B2_HUMAN, PMCA2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01814
- Gene
- ATP2B2
- Ensembl
- ENSG00000157087
- Chromosome
- 3
- Canonical length
- 1243 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1243 residues, UniProt reviewed canonical sequence.
>Q01814|ATP2B2
1 MGDMTNSDFY SKNQRNESSH GGEFGCTMEE LRSLMELRGT EAVVKIKETY GDTEAICRRL
61 KTSPVEGLPG TAPDLEKRKQ IFGQNFIPPK KPKTFLQLVW EALQDVTLII LEIAAIISLG
121 LSFYHPPGEG NEGCATAQGG AEDEGEAEAG WIEGAAILLS VICVVLVTAF NDWSKEKQFR
181 GLQSRIEQEQ KFTVVRAGQV VQIPVAEIVV GDIAQVKYGD LLPADGLFIQ GNDLKIDESS
241 LTGESDQVRK SVDKDPMLLS GTHVMEGSGR MLVTAVGVNS QTGIIFTLLG AGGEEEEKKD
301 KKGVKKGDGL QLPAADGAAA SNAADSANAS LVNGKMQDGN VDASQSKAKQ QDGAAAMEMQ
361 PLKSAEGGDA DDRKKASMHK KEKSVLQGKL TKLAVQIGKA GLVMSAITVI ILVLYFTVDT
421 FVVNKKPWLP ECTPVYVQYF VKFFIIGVTV LVVAVPEGLP LAVTISLAYS VKKMMKDNNL
481 VRHLDACETM GNATAICSDK TGTLTTNRMT VVQAYVGDVH YKEIPDPSSI NTKTMELLIN
541 AIAINSAYTT KILPPEKEGA LPRQVGNKTE CGLLGFVLDL KQDYEPVRSQ MPEEKLYKVY
601 TFNSVRKSMS TVIKLPDESF RMYSKGASEI VLKKCCKILN GAGEPRVFRP RDRDEMVKKV
661 IEPMACDGLR TICVAYRDFP SSPEPDWDNE NDILNELTCI CVVGIEDPVR PEVPEAIRKC
721 QRAGITVRMV TGDNINTARA IAIKCGIIHP GEDFLCLEGK EFNRRIRNEK GEIEQERIDK
781 IWPKLRVLAR SSPTDKHTLV KGIIDSTHTE QRQVVAVTGD GTNDGPALKK ADVGFAMGIA
841 GTDVAKEASD IILTDDNFSS IVKAVMWGRN VYDSISKFLQ FQLTVNVVAV IVAFTGACIT
901 QDSPLKAVQM LWVNLIMDTF ASLALATEPP TETLLLRKPY GRNKPLISRT MMKNILGHAV
961 YQLALIFTLL FVGEKMFQID SGRNAPLHSP PSEHYTIIFN TFVMMQLFNE INARKIHGER
1021 NVFDGIFRNP IFCTIVLGTF AIQIVIVQFG GKPFSCSPLQ LDQWMWCIFI GLGELVWGQV
1081 IATIPTSRLK FLKEAGRLTQ KEEIPEEELN EDVEEIDHAE RELRRGQILW FRGLNRIQTQ
1141 IRVVKAFRSS LYEGLEKPES RTSIHNFMAH PEFRIEDSQP HIPLIDDTDL EEDAALKQNS
1201 SPPSSLNKNN SAIDSGINLT TDTSKSATSS SPGSPIHSLE TSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP2B2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 88 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 88 nTPM
- cerebral cortex: 64 nTPM
- choroid plexus: 61 nTPM
- skeletal muscle: 35 nTPM
- basal ganglia: 35 nTPM
- salivary gland: 31 nTPM
Single-cell type
- choroid plexus epithelial cells: 1,351 nCPM
- brain inhibitory neurons: 336 nCPM
- retinal horizontal cells: 323 nCPM
- brain excitatory neurons: 303 nCPM
- corticotrophs: 283 nCPM
- retinal amacrine cells: 267 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 361 nTPM
- choroid plexus: 229 nTPM
- cerebellum: 214 nTPM
- white matter: 202 nTPM
- thalamus: 169 nTPM
- basal ganglia: 141 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP2B2.
Disease | AllUniProt
Conditions ATP2B2 is implicated in, by any mechanism.
- Deafness, autosomal dominant, 82 (DFNA82) MIM:619804
Disease | GeneticClinVar
53 pathogenic / likely-pathogenic of 625 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hearing loss, autosomal dominant 82
- ATP2B2-related disorder
- Neurodevelopmental disorder
- Epileptic encephalopathy
- Autosomal dominant nonsyndromic hearing loss
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.55
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transport
- monoatomic ion transmembrane transport
- neuron differentiation
- regulation of cardiac conduction
- regulation of cytosolic calcium ion concentration
- sensory perception of sound
Molecular functions
- ATP binding
- ATP hydrolysis activity
- calcium ion binding
- calmodulin binding
- metal ion binding
- P-type calcium transporter activity
- PDZ domain binding
- P-type calcium transporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-type ATPase
- Cation-transporting P-type ATPase, N-terminal
- Cation-transporting P-type ATPase, C-terminal
- P-type ATPase, subfamily IIB
- P-type ATPase, A domain superfamily
- P-type ATPase, phosphorylation site
- Plasma membrane calcium transporting P-type ATPase, C-terminal
- HAD superfamily
- P-type ATPase, transmembrane domain superfamily
- P-type ATPase, cytoplasmic domain N
- HAD-like superfamily
- P-type ATPase, haloacid dehalogenase domain
- P-type ATPase, A domain
- P-type ATPase actuator domain
- Cation transporting ATPase, C-terminus
- Cation transporter/ATPase, N-terminus
- haloacid dehalogenase-like hydrolase
- Plasma membrane calcium transporter ATPase C terminal
- P-type ATPase, cytoplasmic domain N
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP2B2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP2B2 as an antibody target. Whether an autoantibody or antibody against ATP2B2 could matter depends on whether native ATP2B2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP2B2 is annotated at the cell surface, where native ATP2B2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ATP2B2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...